A new device to examine raised level of proteins during inflammation

A feasibility study for microfluidic devices for inflammatory protein

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN36896846

Enrollment

Registered

2026-02-12

Start date

2026-02-23

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory infection/inflammation Respiratory

Interventions

Informed consent: Informed consent will be obtained by the research practitioner (GCP trained) and Principal Investigator and members of the research team on the delegation log. The patients who fulfi

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Participant is willing and able to give informed consent for participation in the study 2. Age >18 years 3. Admitted to the hospital with suspected lung infection (acute exacerbation of COPD, pneumonia, hospital or ventilator associated pneumonia) 4. Less than 72 hours within admission

Exclusion criteria

Exclusion criteria: 1. Potential sources of infection or inflammation outside lungs according to the treating clinician 2. Patients without the capacity to consent 3. Underlying malignancy

Countries

England, United Kingdom

Contacts

Public ContactRahuldeb Sarkar

rahuldeb.sarkar1@nhs.net+44 (0)1634833907

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026